JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
4526
DELISTED
Y-mAbs Therapeutics
YMAB
| $610K | ﹤0.01% |
37,570
+1,690
| +5% | +$36.1K |
|
|
APPH
4527
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $610K | ﹤0.01% |
156,821
-24,305
| -13% | -$130K |
|
|
BTRS
4528
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $610K | ﹤0.01% |
78,074
+37,156
| +91% | +$322K |
|
4529
Valaris
VAL
$5.95B
| $609K | ﹤0.01% |
+16,913
| New | +$589K |
|
|
VEV
4530
DELISTED
Vicinity Motor Corp. Common Stock
VEV
| $607K | ﹤0.01% |
80,900
+35,187
| +77% | +$148K |
|
4531
Liberty Broadband Class A
LBRDA
$5.21B
| $605K | ﹤0.01% |
3,762
+3,149
| +514% | +$510K |
|
|
GOEV
4532
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $602K | ﹤0.01% |
169
+10
| +6% | +$39.9K |
|
4533
First Bancorp
FNLC
$402M
| $600K | ﹤0.01% |
19,083
+7,918
| +71% | +$240K |
|
|
EIGR
4534
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $598K | ﹤0.01% |
3,837
-32
| -0.8% | -$6.19K |
|
4535
PUT
Equity Residential
EQR
$24.7B
| $597K | ﹤0.01% |
6,600
-152,500
| -96% | -$13.1M |
|
4536
Tiptree Inc
TIPT
$672M
| $596K | ﹤0.01% |
43,128
+14,169
| +49% | +$198K |
|
4537
UroGen Pharma
URGN
$2.35B
| $595K | ﹤0.01% |
62,587
-2,426
| -4% | -$34.2K |
|
4538
Ouster
OUST
$3.51B
| $591K | ﹤0.01% |
11,362
+8,640
| +317% | +$561K |
|
|
RXDX
4539
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $591K | ﹤0.01% |
14,952
+10,606
| +244% | +$332K |
|
|
BLFY
4540
DELISTED
Blue Foundry Bancorp
BLFY
| $590K | ﹤0.01% |
40,335
+8,033
| +25% | +$116K |
|
4541
ClearPoint Neuro
CLPT
$468M
| $590K | ﹤0.01% |
52,633
+1,413
| +3% | +$21.2K |
|
4542
VSE Corp
VSEC
$6.79B
| $590K | ﹤0.01% |
9,668
+5,753
| +147% | +$322K |
|
|
CNH
4543
CALL
CNH Industrial
CNH
$16.8B
| $589K | ﹤0.01% |
+34,815
| New | +$533K |
|
4544
Peabody Energy
BTU
$3.11B
| $588K | ﹤0.01% |
58,375
+28,611
| +96% | +$347K |
|
|
ESPR
4545
DELISTED
Esperion Therapeutics
ESPR
| $587K | ﹤0.01% |
117,303
+30,848
| +36% | +$247K |
|
4546
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $586K | ﹤0.01% |
813
+790
| +3,435% | +$756K |
|
4547
PUT
Tilray
TLRY
$636M
| $586K | ﹤0.01% |
8,342
| – | – |
|
4548
Kamada
KMDA
$437M
| $585K | ﹤0.01% |
88,916
-23,272
| -21% | -$139K |
|
|
WSR
4549
DELISTED
Whitestone REIT
WSR
| $585K | ﹤0.01% |
57,790
+7,638
| +15% | +$74.4K |
|
4550
Capitol Federal Financial
CFFN
$1.08B
| $584K | ﹤0.01% |
51,552
-29,398
| -36% | -$346K |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.